RedHill Raises $40M In ADS Offering

July 20, 2015 | The Israeli biopharmaceutical company RedHill BioPharma announced that it raised $40 million through its American Depository Shares at a price of $16.25 per share. The company will reportedly use the money raised in its ADS offering to being Phase III clinical trials on its product for the treatment of the bacteria responsible for causing ulcers. RedHill BioPharma is based in Ramat Gan, Israel.